News
03-17-2023, 08:46 AM
TALAPRO-2, a study led by Neeraj Agarwal, MD, FASCO, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progression or death by 37%.
More... (https://www.news-medical.net/news/20230317/Drug-combination-may-reduce-the-risk-of-prostate-cancer-progression-death.aspx)
More... (https://www.news-medical.net/news/20230317/Drug-combination-may-reduce-the-risk-of-prostate-cancer-progression-death.aspx)